We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Tag: liver disease
MedXY News
EnglishTag

liver disease

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationbiomarkerscritical careclinical trialsHypertensionartificial intelligenceCardiologyoncologypublic healthtype 1 diabetesdiabetesMortalityAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Tag

Beyond Cirrhosis: Understanding Major Adverse Liver Outcomes in Alpha-1 Antitrypsin Deficiency Genotypes
Gastroenterologyliver diseaseGenotype risk

Beyond Cirrhosis: Understanding Major Adverse Liver Outcomes in Alpha-1 Antitrypsin Deficiency Genotypes

By MedXY|Aug 31, 2026

Alpha-1 antitrypsin deficiency (AATD) Z-allele carriers, including heterozygotes and homozygotes, exhibit progressively increased risk of adverse liver outcomes, emphasizing the need for early diagnosis and vigilant monitoring.

Development and Validation of a Noninvasive Score for At-Risk Metabolic Dysfunction-Associated Steatohepatitis in Individuals with Obesity Undergoing Bariatric Surgery
Diabetes & Endocrinology
bariatric surgery
liver disease

Development and Validation of a Noninvasive Score for At-Risk Metabolic Dysfunction-Associated Steatohepatitis in Individuals with Obesity Undergoing Bariatric Surgery

By MedXY|Jul 5, 2026

Researchers developed and validated the FMO score, a noninvasive, cost-effective tool to identify at-risk metabolic dysfunction-associated steatohepatitis (MASH) in obese patients, showing strong predictive performance across multiple inter

Innovative DREAM Technique Restores Intestinal and Hepatic Function in Short Bowel Syndrome
GastroenterologyDREAM techniqueHội chứng ruột ngắn

Innovative DREAM Technique Restores Intestinal and Hepatic Function in Short Bowel Syndrome

By MedXY|Jul 1, 2026

The DREAM method enables complete enteral nutrition in short bowel syndrome, enhancing intestinal adaptation and protecting liver function by restoring gut-liver signaling pathways, as demonstrated in a neonatal pig model.

Oral Glucose Absorption Enhanced in Early Metabolic Dysfunction-Associated Steatotic Liver Disease
Diabetes & Endocrinologyglucose absorptioninsulin resistance

Oral Glucose Absorption Enhanced in Early Metabolic Dysfunction-Associated Steatotic Liver Disease

By MedXY|Apr 30, 2026

New research reveals accelerated glucose absorption in early MASLD patients, independent of gastric emptying. This metabolic alteration may drive liver disease progression before hepatic insulin resistance develops.

The Gut-Liver Axis Unveiled: How Microbiome Signatures Track Disease Progression from Fatty Liver to Cancer
Gastroenterologybiomarkersgut-liver axis

The Gut-Liver Axis Unveiled: How Microbiome Signatures Track Disease Progression from Fatty Liver to Cancer

By MedXY|Apr 5, 2026

A landmark multicohort study of 1,168 individuals reveals that gut microbiome diversity systematically declines across liver disease stages, with specific bacterial markers like Veillonella and functional metabolic shifts predicting disease

Incident Splenomegaly: Defining Clinical Thresholds for Hematologic Cancer and Liver Disease Risk
GastroenterologyHematology-oncologyliver disease

Incident Splenomegaly: Defining Clinical Thresholds for Hematologic Cancer and Liver Disease Risk

By MedXY|Jan 29, 2026

This large-scale prospective cohort study identifies specific spleen length and volume thresholds that significantly increase the 5-year risk of hematologic malignancies and liver disease, providing a data-driven framework for clinical work

Elafibranor Shows Promise as a Safe and Effective Therapy for Primary Sclerosing Cholangitis: Insights from the Phase II ELMWOOD Trial
Gastroenterologyliver diseaseprimary sclerosing cholangitis

Elafibranor Shows Promise as a Safe and Effective Therapy for Primary Sclerosing Cholangitis: Insights from the Phase II ELMWOOD Trial

By MedXY|Oct 29, 2025

The phase II ELMWOOD trial demonstrates that elafibranor, a dual PPAR-α/δ agonist, is well tolerated and significantly improves biochemical markers in patients with primary sclerosing cholangitis over 12 weeks, warranting further investigat

Persistent High Mortality in Severe Alcohol-Associated Hepatitis: Insights from a Five-Decade Meta-Analysis
Gastroenterologyliver diseaseMortality

Persistent High Mortality in Severe Alcohol-Associated Hepatitis: Insights from a Five-Decade Meta-Analysis

By MedXY|Oct 9, 2025

This meta-analysis reveals that short-term mortality in severe alcohol-associated hepatitis remains high, with no significant improvement over the past four decades despite advances in care, underscoring the urgent need for better therapies

Seven Groups Who Should Avoid Fish Oil: Essential Precautions You Must Know
Family Medicine & Nutritionallergiesdiabetes

Seven Groups Who Should Avoid Fish Oil: Essential Precautions You Must Know

By MedXY|Oct 1, 2025

Fish oil offers health benefits but is not suitable for everyone. Learn about the seven groups who should avoid fish oil to prevent health risks and ensure safe supplement use.

Severe Childhood Obesity Linked to Elevated Health Risks
Diabetes & Endocrinologychildhood obesitydiabetes

Severe Childhood Obesity Linked to Elevated Health Risks

By MedXY|Sep 30, 2025

A new study highlights the growing prevalence of extreme pediatric obesity in the U.S. and its association with serious metabolic and cardiovascular health risks, emphasizing the need for targeted interventions.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities